Minesh Mehta, MD
Enriched profileProfessor and Founding Chair, Department of Oncological Sciences, FIU Herbert Wertheim College of Medicine; Deputy Director and Chief of Radiation Oncology, Miami Cancer Institute (Baptist Health South Florida); John and Mary Lou Dasburg Endowed Chair in Radiation Oncology · Florida International University Herbert Wertheim College of Medicine
Minesh Mehta is Professor and Founding Chair, Department of Oncological Sciences, FIU Herbert Wertheim College of Medicine; Deputy Director and Chief of Radiation Oncology, Miami Cancer Institute (Baptist Health South Florida); John and Mary Lou Dasburg Endowed Chair in Radiation Oncology at Florida International University Herbert Wertheim College of Medicine. OpenAlex indexes 1,693 publications with 71,705 citations (h-index 131); ClinicalTrials.gov lists 11 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Minesh Prafulchandra Mehta is Professor and Founding Chair, Department of Oncological Sciences, FIU Herbert Wertheim College of Medicine at Florida International University Herbert Wertheim College of Medicine (Department of Oncological Sciences) / Miami Cancer Institute, Baptist Health South Florida -- NOTE: this contradicts the task-provided 'known institution' of Columbia University. Confirmed by the ORCID record's own employment history (pub.orcid.org API, fetched directly), which shows no Columbia affiliation across the person's entire documented career (Wisconsin, Northwestern, Maryland, Baptist Health/MCI, FIU).. The public record shows 1,693 publications with 71,705 citations (h-index 131), centered on Glioma Diagnosis and Treatment, Brain Metastases and Treatment, Advanced Radiotherapy Techniques. It also documents an investigator role on 11 registered clinical trials.
- Most recent indexed publication: 2026 · Neuro-oncology
- Top research focus: Glioma Diagnosis and Treatment
- 11 registered trials on ClinicalTrials.gov
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 33 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 614.
Clinical & industry
trials, payments and federal fundingNot shown. No U.S. clinical registration on file.
Federally funded research awards.
Public positions
sourced statements on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →theorg.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →theorg.com ↗
This is a research profile, built on the published record. There's no U.S. clinical registration (NPI) on file, so facts that hang off one (clinical specialty, industry payments) aren't shown. We'd rather leave a gap than guess. Why? →
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
Herbert Wertheim College of Medicine, 11200 SW 8th Street, AHC2, Miami, FL 33199
Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 11 registered studies on ClinicalTrials.gov. The most recent:
- Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases
Sponsor: Baptist Health South Florida
Industry payments
Not shown. This person has no U.S. clinical registration (NPI) on file, so we can't reliably tie industry payments reported to CMS to them. We'd rather leave a gap than guess. Why? →
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Reply to: Blood-Brain Barrier Heterogeneity in NRG BN007: Implications for Immunotherapy Delivery.
Journal of clinical oncology
Article2026
Most-cited works
by citation count (OpenAlex)- 01A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma2,794 citations2014
- 02
- 03
- 04
- 05
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/minesh-mehta-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/minesh-mehta-35641318a
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Minesh-Mehta
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Other
ascopost.com/videos/2024-asco-annual-meeting/minesh-p-mehta-on-nsclc-tumor-treating-fields-for-brain-metastases
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗ - Other
onclive.com/authors/minesh-mehta-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗ - Society profile
amportal.astro.org/minesh-mehta-md-mb-chb-fastro-1962711
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →amportal.astro.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.fiu.edu ↗
- M.D.
University of Zambia School of Medicine (1981, graduated with highest honors); MB, ChB credential also listed
1981verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗ - Board Certified
Radiation Oncology, American Board of Radiology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Board Certified
Neuro-Oncology, United Council for Neurologic Subspecialties
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.fiu.edu ↗
Editorial & leadership roles
journal and society appointments- Member
American Society for Radiation Oncology (ASTRO) Board of Directors (since 2006); specific board title/chair status not independently confirmed
2006provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →redjournal.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →amportal.astro.org ↗
- Editorial board member
International Journal of Radiation Oncology, Biology, Physics (Red Journal)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →redjournal.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →southfloridahospitalnews.com ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org ↗
- Former Professor
Radiation Oncology, Northwestern University Feinberg School of Medicine incl. Robert H. Lurie Comprehensive Cancer Center (Oct 2010-Sep 2012) …
2012verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org ↗
Media & interviews
press, podcasts and appearances- Video interview: 'Minesh P. Mehta
MD, on NSCLC: Tumor Treating Fields for Brain Metastases', The ASCO Post, 2024 ASCO Annual Meeting, discussing METIS (EF-25) trial results
2024verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncodaily.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →vjoncology.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Patrick Wen, MD
Dana-Farber Cancer Institute
David Reardon, MD
Dana-Farber Cancer Institute
Evanthia Galanis, MD
Mayo Clinic
Manmeet Ahluwalia, MD
Baptist Health Miami Cancer Institute